section name header

Information

Pharyngitis After an incubation period of 1-4 days, pts develop sore throat, fever, chills, malaise, and GI manifestations.

Treatment: GAS Pharyngitis

  • See Table 87-1 for recommended treatments.
    • - The primary goal of treatment is to prevent suppurative complications (e.g., lymphadenitis, abscess, sinusitis, bacteremia, pneumonia) and ARF; therapy does not seem to significantly reduce the duration of symptoms or to prevent PSGN.
    • - Follow-up cultures after completion of therapy are not routinely recommended.
  • Asymptomatic pharyngeal GAS carriage usually is not treated; however, when the pt is a potential source of infection in others (e.g., health care workers), either clindamycin (300 mg PO tid for 10 days) or penicillin V (500 mg PO qid for 10 days) with rifampin (300 mg PO bid for the first 4 days) is used.

Scarlet Fever Scarlet fever is the designation for GAS infection—usually pharyngitis—associated with a characteristic rash. It is much less common now than in the past.

Skin and Soft Tissue Infections See Chap. 84. Infections of the Skin, Soft Tissues, Joints, and Bones for further discussion of clinical manifestations and treatment.

Pneumonia and Empyema GAS is an occasional cause of pneumonia in previously healthy pts.

Bacteremia In most cases of GAS bacteremia, a focus is readily identifiable. Bacteremia occurs occasionally with cellulitis or pneumonia and frequently with necrotizing fasciitis.

Toxic Shock Syndrome Unlike those with TSS due to S. aureus, pts with streptococcal TSS generally lack a rash, have bacteremia, and have an associated soft tissue infection (cellulitis, necrotizing fasciitis, or myositis).

Outline

Section 7. Infectious Diseases